Conflu3nce

Image-based Solutions for Visual-processing Disorders

Company Name
Updating Date
Neurotech Category
Market Category
Target Market
Technologies
Company Founded Year
Company Number of Employees
Conflu3nce
02/07/2022
Cognitive Assessment & Enhancement
Digital & Health care
General wellbeing / wellness (users without clinical diagnosis)
Image (/Video) Processing | Motion Tracking
01/01/2016
"1-10"

Conflu3nce applies patented and patent-pending methods to develop diagnostic, treatment, and rehabilitation tools to increase the capacity of people affected by visual-processing and visual-cognition differences and deficits. Conflu3nce is currently developing a minimally disruptive, non-pharmaceutical approach to address attention, executive function, and visual-cognition-related issues for people with Alzheimer's disease, traumatic brain injury, stroke, and attention deficit/hyperactivity disorder.



The system's multi-modal, multi-domain-based activities are designed to cooperatively engage global cognition and can be delivered as hands-on and virtual/view-only experiences.



The company's technology, the PICSS Interactive platform, is based on processes and methods that use content-rich, dynamic, 3D-like figure-ground image sets with image properties that can be manipulated. Users are guided through a series of progressively challenging interactions designed to help cooperatively develop and retrain skills, processes, and processing.



Through therapeutic gameplay, PICSS Interactive users can improve their eye-tracking skills and associated visual-cognition processes including memory, pattern recognition, scanning, visual attention, and closure.